10

Home >> 2024 >> September >> 10

The first and last authors of the study in front of the heart research building of the University Medical Center Göttingen (from left to right): Dominik Hubricht, medical student; Dr Fleur Mason, postdoctoral researcher; Vanessa Möller, medical student; Dr Funsho Fakuade, postdoctoral researcher and Prof Dr Niels Voigt, Professor of Molecular Pharmacology at the Institute of Pharmacology and Toxicology. Photo: Julia Szikszay

10.09.2024

Defective ‘shock absorber’ in heart muscle cells contributes to the development of atrial fibrillation

Impaired calcium buffering in heart muscle cells promotes the progression and perpetuation of atrial fibrillation. This was discovered by researchers from the Heart Center of the University Medical Center Göttingen (UMG) and the German Centre for Cardiovascular Research (DZHK). The findings offer potential starting points for new therapies. The results
Learn More
10.09.2024

Animal experiments in science

Salon Debate on September 17, 2024 at Forum Wissen   „Animal experiments in science“ is the topic of an event on Tuesday, September 17, 2024, at 6.30 p.m. in the Forum Wissen at the University of Göttingen. It is part of the “Salon Debates” series, which addresses current issues from
Learn More

The first and last authors of the study in front of the heart research building of the University Medical Center Göttingen (from left to right): Dominik Hubricht, medical student; Dr Fleur Mason, postdoctoral researcher; Vanessa Möller, medical student; Dr Funsho Fakuade, postdoctoral researcher and Prof Dr Niels Voigt, Professor of Molecular Pharmacology at the Institute of Pharmacology and Toxicology. Photo: Julia Szikszay

10.09.2024

Defective ‘shock absorber’ in heart muscle cells contributes to the development of atrial fibrillation

Impaired calcium buffering in heart muscle cells promotes the progression and perpetuation of atrial fibrillation. This was discovered by researchers from the Heart Center of the University Medical Center Göttingen (UMG) and the German Centre for Cardiovascular Research (DZHK). The findings offer potential starting points for new therapies. The results
Learn More
Feature image not available
10.09.2024

KRASG12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening

Authors Tapia Contreras C, Falke JD, Seifert DM, Schneider C, Krauß L, Fang X, Müller D, Demirdizen E, Spitzner M, De Oliveira T, Schneeweis C, Gaedcke J, Kaulfuß S, Mirzakhani K, Wollnik B, Conrads K, Beißbarth T, Salinas G, Hügel J, Beyer N, Rheinländer S, Sax U, Wirth M, Conradi
Learn More
X

Open Positions

EN DE
X
X